Clinical trial Recruiting at 12 sites Observational Ages 18 and up

Reperfusion options for acute pulmonary embolism

Official title: Reperfusion Treatment in Acute Pulmonary Embolism: A Multicenter Observational Study in the Nordic Countries

Run by Sahlgrenska University Hospital · NCT07003646 · Data updated 2026-11-12

This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment220 (estimated)
SponsorSahlgrenska University Hospital
Academic / other
Locations13 sites (Aarhus and 12 other locations)
StatusRecruiting
StartedApril 1, 2025
Main results expectedMay 1, 2028
Study endsMay 1, 2029
Registry record updatedJanuary 21, 2026
Trial IDNCT07003646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with confirmed acute pulmonary embolism who are planned for or have received catheter-directed intervention or systemic thrombolysis, including pregnant women, are eligible.

Probably not a fit

Patients undergoing surgical embolectomy as the primary reperfusion treatment or those already enrolled in an interventional catheter-directed trial are not expected to benefit from this observational comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PE-NORDIC is a multicenter observational effort comparing outcomes for adults with acute pulmonary embolism who receive catheter-directed interventions (including mechanical thrombectomy devices such as FlowTriever® and catheter-directed thrombolysis) versus systemic thrombolysis. The study will collect real-world data from participating Nordic hospitals on survival, hemodynamic response, and bleeding complications. It is non-randomized and enrolls patients who are planned for or have already received these reperfusion methods, with a waiver of consent allowed if patients die before consent can be obtained. The project aims to describe how current reperfusion strategies perform in routine clinical practice across the region.

Why it matters

Potential benefit: If successful, it could help identify which reperfusion approach provides better survival and fewer serious bleeding complications for patients with high-risk or deteriorating pulmonary embolism.

How similar studies have gone: Industry-sponsored and single-arm trials have shown promising hemodynamic improvements with devices like FlowTriever, but randomized comparisons between catheter-directed interventions and standard care are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All adult patients (≥18 years), including pregnant women, with verified (CTPA, angiography or scintigraphy) acute pulmonary embolism who are planned for, or have received, treatment with catheter directed intervention or systemic thrombolysis
* Informed consent (for patients who do not survive before informed consent can be obtained, a waiver of consent applies)

Exclusion Criteria:

* Ongoing enrolment in interventional catheter directed intervention trial
* Surgical embolectomy as primary reperfusion treatment

Where it's running

  • Aarhus University Hospital
    Aarhus, Denmark
    Recruiting
  • Rigshospitalet
    Copenhagen, Denmark
    Recruiting
  • Odense University Hospital
    Odense, Denmark
    Recruiting
  • Sahlgrenska University Hospital
    Gothenburg, Sweden
    Recruiting
  • Linköping University Hospital
    Linköping, Sweden
    Recruiting
  • Sunderby Hospital
    Luleå, Sweden
    Recruiting
Show 7 more locations
  • Skåne University Hospital
    Lund, Sweden
    Recruiting
  • Örebro University Hospital
    Örebro, Sweden
    Recruiting
  • Danderyd Hospital
    Stockholm, Sweden
    Recruiting
  • Karolinska University Hospital Huddinge
    Stockholm, Sweden
    Recruiting
  • Karolinska University Hospital Solna
    Stockholm, Sweden
    Recruiting
  • Södersjukhuset
    Stockholm, Sweden
    Recruiting
  • Uppsala University Hospital
    Uppsala, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.